Cobblestone Capital Advisors LLC NY Has $7.79 Million Stock Position in CVS Health Co. (NYSE:CVS)

Cobblestone Capital Advisors LLC NY raised its position in CVS Health Co. (NYSE:CVS) by 4.5% in the 2nd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 131,901 shares of the pharmacy operator’s stock after acquiring an additional 5,704 shares during the period. Cobblestone Capital Advisors LLC NY’s holdings in CVS Health were worth $7,790,000 as of its most recent SEC filing.

Other large investors have also recently added to or reduced their stakes in the company. USA Financial Formulas grew its stake in shares of CVS Health by 573.2% in the 4th quarter. USA Financial Formulas now owns 377 shares of the pharmacy operator’s stock valued at $30,000 after purchasing an additional 321 shares during the period. Ables Iannone Moore & Associates Inc. bought a new stake in shares of CVS Health in the 4th quarter valued at approximately $32,000. Creekmur Asset Management LLC bought a new stake in shares of CVS Health in the 4th quarter valued at approximately $34,000. Steph & Co. grew its stake in shares of CVS Health by 192.0% in the 1st quarter. Steph & Co. now owns 438 shares of the pharmacy operator’s stock valued at $35,000 after purchasing an additional 288 shares during the period. Finally, Kapitalo Investimentos Ltda bought a new stake in shares of CVS Health in the 4th quarter valued at approximately $36,000. Institutional investors and hedge funds own 80.66% of the company’s stock.

Analyst Ratings Changes

Several research analysts have recently commented on CVS shares. Barclays reduced their target price on CVS Health from $65.00 to $63.00 and set an “equal weight” rating on the stock in a report on Thursday, August 8th. JPMorgan Chase & Co. reduced their price objective on CVS Health from $101.00 to $86.00 and set an “overweight” rating on the stock in a research note on Thursday, May 30th. Cantor Fitzgerald restated a “neutral” rating and issued a $62.00 target price on shares of CVS Health in a research note on Monday, August 19th. Robert W. Baird assumed coverage on shares of CVS Health in a report on Thursday, May 30th. They set a “neutral” rating and a $61.00 price objective on the stock. Finally, Evercore ISI dropped their target price on shares of CVS Health from $65.00 to $62.00 and set an “outperform” rating for the company in a research note on Thursday, August 8th. Eleven investment analysts have rated the stock with a hold rating and twelve have given a buy rating to the company’s stock. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $72.48.

CVS Health Trading Down 0.6 %

Shares of NYSE CVS traded down $0.32 during midday trading on Friday, reaching $57.75. 6,263,025 shares of the stock were exchanged, compared to its average volume of 11,149,185. The business has a 50-day simple moving average of $58.29 and a two-hundred day simple moving average of $63.86. The company has a market capitalization of $72.50 billion, a price-to-earnings ratio of 10.15, a P/E/G ratio of 0.80 and a beta of 0.53. CVS Health Co. has a 12 month low of $52.77 and a 12 month high of $83.25. The company has a debt-to-equity ratio of 0.83, a current ratio of 0.86 and a quick ratio of 0.66.

CVS Health (NYSE:CVS) last announced its quarterly earnings results on Wednesday, August 7th. The pharmacy operator reported $1.83 earnings per share for the quarter, topping analysts’ consensus estimates of $1.73 by $0.10. The company had revenue of $91.23 billion for the quarter, compared to analysts’ expectations of $91.41 billion. CVS Health had a net margin of 1.98% and a return on equity of 12.72%. The business’s quarterly revenue was up 2.6% compared to the same quarter last year. During the same period last year, the firm posted $2.21 earnings per share. As a group, equities research analysts expect that CVS Health Co. will post 6.52 EPS for the current year.

CVS Health Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Thursday, August 1st. Stockholders of record on Monday, July 22nd were given a dividend of $0.665 per share. The ex-dividend date of this dividend was Monday, July 22nd. This represents a $2.66 dividend on an annualized basis and a dividend yield of 4.61%. CVS Health’s dividend payout ratio is 46.75%.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.